<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7333627\results\search\disease\results.xml">
  <result pre="font-style : italic;} J InfectJ. InfectThe Journal of Infection0163-44531532-2742The British" exact="Infection" post="Association. Published by Elsevier Ltd. pmcid: 7333627S0163-4453(20)30458-8 doi: 10.1016/j.jinf.2020.06.077"/>
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="as the COVID-19 resource centre remains active. Dear Editor, Coronavirus" exact="disease" post="2019 (COVID-19) pandemic is causing huge impacts on health"/>
  <result pre="with mild symptoms, but suggest to prescribe antibiotics for suspicious" exact="bacterial" post="infections.1,2 The US National Institutes of Health guideline3 indicates"/>
  <result pre="pandemic outbreak. Learnt from the past influenza epidemics or pandemics," exact="bacterial" post="co/secondary infection is one of the major causes of"/>
  <result pre="Learnt from the past influenza epidemics or pandemics, bacterial co/secondary" exact="infection" post="is one of the major causes of fatalities. Antibiotic"/>
  <result pre="a reasonable approach to reduce potential morbidity and mortality in" exact="lower" post="and upper respiratory infections such as pneumonia with unclear"/>
  <result pre="approach to reduce potential morbidity and mortality in lower and" exact="upper" post="respiratory infections such as pneumonia with unclear aetiological agents."/>
  <result pre="to reduce potential morbidity and mortality in lower and upper" exact="respiratory" post="infections such as pneumonia with unclear aetiological agents. Therefore,"/>
  <result pre="reduce potential morbidity and mortality in lower and upper respiratory" exact="infections" post="such as pneumonia with unclear aetiological agents. Therefore, during"/>
  <result pre="and mortality in lower and upper respiratory infections such as" exact="pneumonia" post="with unclear aetiological agents. Therefore, during the Severe Acute"/>
  <result pre="such as pneumonia with unclear aetiological agents. Therefore, during the" exact="Severe" post="Acute Respiratory Syndrome (SARS) outbreak in 2003 and the"/>
  <result pre="as pneumonia with unclear aetiological agents. Therefore, during the Severe" exact="Acute" post="Respiratory Syndrome (SARS) outbreak in 2003 and the more"/>
  <result pre="pneumonia with unclear aetiological agents. Therefore, during the Severe Acute" exact="Respiratory" post="Syndrome (SARS) outbreak in 2003 and the more recent"/>
  <result pre="with unclear aetiological agents. Therefore, during the Severe Acute Respiratory" exact="Syndrome" post="(SARS) outbreak in 2003 and the more recent Middle"/>
  <result pre="(SARS) outbreak in 2003 and the more recent Middle East" exact="Respiratory" post="Syndrome (MERS) outbreak in 2012, most suspected patients were"/>
  <result pre="outbreak in 2003 and the more recent Middle East Respiratory" exact="Syndrome" post="(MERS) outbreak in 2012, most suspected patients were administrated"/>
  <result pre="(nâ€¯=â€¯99) received antibiotic treatment and only 1 (1%) patients developed" exact="bacterial" post="co-infection.7 Later, Zhou etÂ al. studied a bigger cohort"/>
  <result pre="181 (95%) patients received antibiotics and 28 (15%) patients suffered" exact="secondary" post="infections including 1 (1%) of 137 survivors and 27"/>
  <result pre="(95%) patients received antibiotics and 28 (15%) patients suffered secondary" exact="infections" post="including 1 (1%) of 137 survivors and 27 (50%)"/>
  <result pre="between 1 January 2020 to 17 April 2020 for studying" exact="secondary" post="infections in COVID-19 patients. From their results, only 7%"/>
  <result pre="1 January 2020 to 17 April 2020 for studying secondary" exact="infections" post="in COVID-19 patients. From their results, only 7% of"/>
  <result pre="From their results, only 7% of hospitalised COVID-19 patients had" exact="bacterial" post="co-infections. Remarkably, Lansbury's analysis showed that 17 out of"/>
  <result pre="co-infections in COVID-19 patients. Future development in fast diagnosis for" exact="infectious" post="agents based on genomics or proteomics identification will provide"/>
  <result pre="or proteomics identification will provide timely and accurate information for" exact="disease" post="management. It is essential to develop evidence-based guidelines for"/>
  <result pre="interests. References References 1COVID-19 rapid guideline: managing suspected or confirmed" exact="pneumonia" post="in adults in the community, 2020. Available at https://www.nice.org.uk/guidance/ng165."/>
  <result pre="https://www.who.int/publications/i/item/clinical-management-of-covid-19. Accessed [June 24 2020]. 3COVID-19 Treatment Guidelines Panel. Coronavirus" exact="disease" post="2020 (COVID-19) treatment guidelines. National Institutes of Health, 2020."/>
  <result pre="https://www.covid19treatmentguidelines.nih.gov/. Accessed [June 24 2020]. 4Chinese Clinical Guidance for COVID-19" exact="Pneumonia" post="Diagnosis and Treatment (7th edition in Chinese), 2020. Available"/>
  <result pre="5TsangK.ZhongN.S.SARS: pharmacotherapyRespirology82003S25S3015018130 6RabaanA.A.AlahmedS.H.BazziA.M.AlhaniH.MA review of candidate therapies for Middle East" exact="respiratory" post="syndrome from a molecular perspectiveJ Med Microbiol6620171261127428855003 7ChenN.ZhouM.DongX.QuJ.GongF.HanY.Epidemiological and"/>
  <result pre="pharmacotherapyRespirology82003S25S3015018130 6RabaanA.A.AlahmedS.H.BazziA.M.AlhaniH.MA review of candidate therapies for Middle East respiratory" exact="syndrome" post="from a molecular perspectiveJ Med Microbiol6620171261127428855003 7ChenN.ZhouM.DongX.QuJ.GongF.HanY.Epidemiological and clinical"/>
  <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive studyLancet395202050751332007143 8ZhouF.YuT.DuR.FanG.LiuY.LiuZ.Clinical course and"/>
  <result pre="descriptive studyLancet395202050751332007143 8ZhouF.YuT.DuR.FanG.LiuY.LiuZ.Clinical course and risk factors for mortality of" exact="adult" post="inpatients with COVID-19 in Wuhan, China: a retrospective cohort"/>
 </snippets>
</snippetsTree>
